Icu Medical [ICUI] vs Becton, Dickinson [BDX] Detailed Stock Comparison

Icu Medical Inc.

NASDAQ
Loading...

Becton, Dickinson and Company

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Icu Medical Inc. wins in 5 metrics, Becton, Dickinson and Company wins in 15 metrics, with 0 ties. Becton, Dickinson and Company appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Icu Medical Inc. Becton, Dickinson and Company Better
P/E Ratio (TTM) 4,245.33 25.40 Becton, Dickinson and Company
Price-to-Book Ratio 1.48 1.75 Icu Medical Inc.
Debt-to-Equity Ratio 63.48 77.28 Icu Medical Inc.
PEG Ratio -124.79 0.92 Becton, Dickinson and Company
EV/EBITDA 13.48 10.49 Becton, Dickinson and Company
Profit Margin (TTM) 0.03% 8.01% Becton, Dickinson and Company
Operating Margin (TTM) 4.82% 13.35% Becton, Dickinson and Company
EBITDA Margin (TTM) 4.82% 13.35% Becton, Dickinson and Company
Return on Equity 0.04% 6.96% Becton, Dickinson and Company
Return on Assets (TTM) 1.66% 4.08% Becton, Dickinson and Company
Free Cash Flow (TTM) $82.83M $2.67B Becton, Dickinson and Company
Dividend Yield N/A 2.56% N/A
1-Year Return 0.39% 8.43% Becton, Dickinson and Company
Price-to-Sales Ratio (TTM) 1.43 2.57 Icu Medical Inc.
Enterprise Value $4.18B $63.40B Becton, Dickinson and Company
EV/Revenue Ratio 1.87 2.89 Icu Medical Inc.
Gross Profit Margin (TTM) 37.54% 45.91% Becton, Dickinson and Company
Revenue per Share (TTM) $91 $76 Icu Medical Inc.
Earnings per Share (Diluted) $0.03 $6.13 Becton, Dickinson and Company
Beta (Stock Volatility) 0.85 0.35 Becton, Dickinson and Company
Short % of Float 6.25% 3.78% Becton, Dickinson and Company

Icu Medical Inc. vs Becton, Dickinson and Company Stock Performance Analysis

Loading Price Chart...

ICUI
BDX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Icu Medical Inc.0.03%-3.33%9.95%-11.23%-11.03%-5.81%
Becton, Dickinson and Company0.82%-2.25%-1.28%-18.19%-3.55%-5.76%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Icu Medical Inc.0.39%-26.60%-34.21%29.31%223.74%231.11%
Becton, Dickinson and Company8.43%-25.68%-20.29%13.34%123.65%215.10%

Performance & Financial Health Analysis: Icu Medical Inc. vs Becton, Dickinson and Company

MetricICUIBDX
Market Information
Market Cap i$3.11B$56.10B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i266,5752,759,250
90 Day Avg. Volume i286,5122,521,130
Last Close$130.52$145.61
52 Week Range$107.00 - $160.29$127.59 - $187.35
% from 52W High-18.57%-22.28%
All-Time High$321.70 (Aug 06, 2018)$287.32 (Jul 24, 2023)
% from All-Time High-59.43%-49.32%
Growth Metrics
Quarterly Revenue Growth-0.14%0.02%
Quarterly Earnings Growth-0.14%0.26%
Financial Health
Profit Margin (TTM) i0.00%0.08%
Operating Margin (TTM) i0.05%0.13%
Return on Equity (TTM) i0.00%0.07%
Debt to Equity (MRQ) i63.4877.28
Cash & Liquidity
Book Value per Share (MRQ)$86.03$88.79
Cash per Share (MRQ)$12.63$2.64
Operating Cash Flow (TTM) i$179.85M$3.39B
Levered Free Cash Flow (TTM) i$394.96M$3.11B
Dividends
Last 12-Month Dividend Yield iN/A2.56%
Last 12-Month Dividend iN/A$4.18

Valuation & Enterprise Metrics Analysis: Icu Medical Inc. vs Becton, Dickinson and Company

MetricICUI (Apr 24, 2026)BDX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i4,245.3325.40
Forward P/E i13.8611.53
PEG Ratio i-124.790.92
Price to Sales (TTM) i1.432.57
Price to Book (MRQ) i1.481.75
Market Capitalization
Market Capitalization i$3.11B$56.10B
Enterprise Value i$4.18B$63.40B
Enterprise Value Metrics
Enterprise to Revenue i1.872.89
Enterprise to EBITDA i13.4810.49
Risk & Other Metrics
Beta i0.850.35
Book Value per Share (MRQ) i$86.03$88.79

Financial Statements Comparison: Icu Medical Inc. vs Becton, Dickinson and Company

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricICUI (2025)BDX (2025)
Revenue/Sales i2.23B21.84B
Cost of Goods Sold i1.41B11.92B
COGS % of Revenue i63.2%54.6%
Gross Profit i822.04M9.93B
Gross Margin i36.8%45.4%
Research & Development i87.50M1.27B
Operating Income (EBIT) i109.33M2.99B
Operating Margin i4.9%13.7%
EBITDA i320.73M5.42B
EBITDA Margin i14.4%24.8%
Pre-Tax Income i4.36M1.88B
Pre-Tax Income % of Revenue i0.2%8.6%
Income Tax i2.44M203.00M
Income Tax % of Revenue i0.1%0.9%
Net Income (Profit) i732,0001.68B
Profit Margin i0.0%7.7%

Balance Sheet & Liquidity Metrics

MetricICUI (2025)BDX (2025)
Cash & Equivalents i307.96M641.00M
Total Current Assets i1.19B9.26B
Total Current Assets % of Revenue i53.4%42.4%
Total Current Liabilities i498.86M8.31B
Total Current Liabilities % of Revenue i22.4%38.1%
Long-Term Debt i1.31B17.62B
Long-Term Debt % of Revenue i58.9%80.7%
Total Shareholders Equity i2.12B25.39B
Retained Earnings i690.89M16.62B
Retained Earnings % of Revenue i31.0%76.1%
Property, Plant & Equipment i492.78M0

Cash Flow Statement Comparison

MetricICUI (2025)BDX (2025)
Operating Cash Flow i263.01M3.68B
Operating Cash Flow % of Revenue i11.8%16.9%
Capital Expenditures i-88.04MN/A
Free Cash Flow i82.83M2.67B
FCF Margin i3.7%12.2%
Debt Repayment i-304.80M-1.79B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricICUIBDX
Shares Short i1.30M9.49M
Short Ratio i4.683.92
Short % of Float i6.25%3.78%
Shares Outstanding i24.69M284.74M
Float Shares i24.21M283.99M
% Held by Insiders i3.79%0.40%
% Held by Institutions i114.71%96.58%
% Held by Public i-18.50%3.02%

Dividend Analysis & Yield Comparison: Icu Medical Inc. vs Becton, Dickinson and Company

MetricICUIBDX
Last 12-Month Dividend iN/A$4.18
Last 12-Month Dividend Yield iN/A2.56%
3-Year Avg Annual Dividend iN/A$3.96
3-Year Avg Dividend Yield iN/A0.58%
3-Year Total Dividends iN/A$11.88
Ex-Dividend DateN/AMar 10, 2026